Does Gabapentin Increase Serotonin Levels?

Gabapentin does not directly raise serotonin the way an SSRI or similar antidepressant does. Its primary molecular target is a calcium channel subunit in the nervous system, not a serotonin receptor or transporter. That said, a small body of evidence suggests gabapentin can modestly influence serotonin levels through indirect routes, and this secondary relationship turns out to be more nuanced than a simple yes or no.

What Gabapentin Actually Targets

Gabapentin was designed as a structural analog of GABA, the brain’s main inhibitory neurotransmitter, but it does not actually bind to GABA receptors. Instead, its confirmed target is a protein called the alpha-2-delta-1 (α2δ-1) subunit, which is an accessory piece of voltage-gated calcium channels found throughout the nervous system. When gabapentin binds to this subunit, it disrupts the normal trafficking of calcium channels to the cell surface, reducing the flow of calcium into nerve cells. Less calcium influx means less release of excitatory signaling molecules at nerve endings, which is why gabapentin can quiet overactive pain circuits and reduce seizure activity.¹

This mechanism has been validated repeatedly. Studies using genetically altered mice in which the α2δ-1 subunit was either removed or mutated so that gabapentin could no longer bind to it showed that the drug’s pain-relieving effects vanished completely. Molecular and transgenic research strongly supports α2δ-1 as the sole molecular target responsible for gabapentin’s analgesic actions.² Various alternative mechanisms have been proposed over the years, including effects on sodium channels and NMDA receptors, but these have not held up as the primary explanation for what gabapentin does.³

One important detail: gabapentin doesn’t work immediately. It has to be taken into the cell through an amino acid transporter called LAT1 before it can interfere with calcium channel trafficking from the inside. At therapeutic doses, LAT1-mediated transport of gabapentin is several times more efficient than other transport pathways, which helps explain why the drug accumulates in nerve tissue.⁴ The drug’s chronic mechanism, gradually reducing the number of calcium channels on the cell surface rather than flipping a switch, also helps explain why patients often need to take it for days or weeks before feeling full benefit.¹

The Whole-Blood Serotonin Finding

So where does the serotonin story come from? A small study from the late 1980s by Rao and colleagues gave gabapentin to six healthy young men and found that as blood levels of the drug rose, whole-blood serotonin concentrations also went up.⁵ That finding has been cited in pharmacology reviews ever since, and it is the single most commonly referenced piece of evidence when people ask whether gabapentin affects serotonin.

The researchers speculated that the serotonin increase might stem from changes in how platelets handle serotonin, or from shifts in serotonin metabolism. They also noticed that the subjects’ deep sleep stages increased at the same time, which loosely fit the serotonin hypothesis since serotonin is involved in sleep regulation. But the study was tiny, and the authors themselves noted that the in-vitro work to confirm their speculation had not been done.⁶

Critically, “whole blood serotonin” is not the same thing as brain serotonin. Roughly 95% of the body’s serotonin is found outside the brain, mostly in the gut and in platelets circulating in the bloodstream. An increase in whole-blood serotonin could reflect changes in platelet storage or release without any corresponding change in the serotonin that’s actually active in your brain. This distinction matters enormously for anyone wondering whether gabapentin would produce mood or anxiety effects through serotonin pathways.

Gabapentin’s Real Neurochemical Signature Is GABA, Not Serotonin

If gabapentin consistently changed any brain chemical in a clinically meaningful way, the winner is GABA itself, not serotonin. Brain-imaging studies using magnetic resonance spectroscopy have measured GABA levels directly in living human brains before and after gabapentin administration. One study found that a single dose of gabapentin raised brain GABA concentrations by an average of about 48% within six hours. Over four weeks of dosing, the increase settled to around 25% above baseline.⁷

Another imaging study found an even more dramatic average increase of about 56% in brain GABA after gabapentin, with an interesting twist: people who started with lower baseline GABA levels showed the largest increases. The correlation between baseline GABA and the size of the gabapentin-induced change was strong.⁸ Epilepsy patients taking gabapentin also showed elevated brain GABA compared to matched patients on other medications, with higher doses correlating to higher GABA levels.⁹

This is worth emphasizing because many people conflate gabapentin’s calming or anxiolytic effects with serotonin activity. The calming quality of gabapentin is more plausibly explained by increased GABA (an inhibitory neurotransmitter that reduces neuronal excitability) and reduced excitatory calcium-channel signaling than by any serotonin mechanism. When a drug raises brain GABA by 25 to 56%, that effect alone can account for a lot of what patients feel.

The Serotonin Circuit That Matters for Pain

There is, however, a legitimate connection between gabapentin and serotonin, and it shows up in pain research rather than mood or anxiety research. The spinal cord contains descending pain-control pathways that use serotonin and noradrenaline as their signaling molecules. These pathways run from the brainstem down to the spinal cord and can either amplify or dampen pain signals before they reach the brain. In neuropathic pain conditions, these circuits become abnormally active and can actually facilitate pain rather than suppress it.

Gabapentin’s ability to relieve neuropathic pain appears to depend, at least in part, on these serotonergic circuits. Research in rats showed that gabapentin’s pain-relieving effect was completely blocked when a serotonin receptor (the 5-HT3 receptor) was pharmacologically blocked with ondansetron. Even more striking, activating 5-HT3 receptors in normal, uninjured animals allowed gabapentin to produce powerful pain inhibition that it could not otherwise achieve, suggesting the serotonergic circuit acts as a kind of gatekeeper for gabapentin’s analgesic activity.¹⁰

But a more recent study tried to pin down whether gabapentin actually changes serotonin levels in the spinal cord, and the answer was essentially no. In neuropathic rats, researchers found no apparent changes in spinal serotonin before or after gabapentin administration. When they depleted serotonin from the animals’ systems, gabapentin could still relieve pain, although serotonin receptor blockers no longer affected the drug’s action. The study’s conclusion was that serotonin’s involvement in gabapentin’s pain relief is “secondary” and cooperative with the noradrenergic system rather than central to the drug’s mechanism.¹¹

In other words, gabapentin works within a neural circuit that happens to use serotonin, but it doesn’t seem to work by changing how much serotonin is present. The drug interacts with the serotonergic system without being a serotonergic drug, a distinction that’s easy to miss but clinically important.

What About Direct Effects on Serotonin Synthesis?

Researchers have also tested whether gabapentin changes how much serotonin the brain produces. In rat brain tissue, gabapentin by itself did not alter serotonin synthesis in any region measured. However, when researchers artificially stimulated neurotransmitter release using a chemical called 3,4-diaminopyridine (DAP), gabapentin was able to block the resulting surge in serotonin production specifically in the hippocampus.¹²

This fits a pattern that keeps recurring in the literature: gabapentin doesn’t push serotonin levels up or down under normal conditions, but it can blunt abnormal surges. A study testing gabapentin’s anti-vomiting effects in pigeons exposed to cisplatin (a chemotherapy drug that causes intense nausea by triggering massive serotonin release in the gut) found that gabapentin significantly reduced the serotonin spike.¹³ Rather than raising serotonin, gabapentin attenuated it in a context where serotonin was pathologically elevated.

The emerging picture is that gabapentin acts more like a stabilizer than a driver when it comes to serotonin. Under resting conditions, it has minimal direct influence on serotonin levels. Under conditions of abnormal excitation, it can dampen serotonin surges, likely because of its broader effect on calcium-dependent neurotransmitter release. This is a far cry from how SSRIs work, where the explicit goal is to keep serotonin lingering in the synaptic gap by blocking its reuptake.

Gabapentin and Serotonin Syndrome

Despite gabapentin’s lack of direct serotonergic action, it has shown up in case reports of serotonin syndrome, a potentially dangerous condition caused by excessive serotonin activity. A systematic review of case reports involving antiepileptic drugs and serotonin syndrome found that gabapentin was implicated in about 21% of reported cases. However, the vast majority of those patients, roughly 88%, were also taking other drugs with known serotonergic activity. Only about 12% of patients in the review were taking antiepileptic drugs alone when serotonin syndrome developed.¹⁴

Case reports have specifically noted the serotonin-boosting observation from the Rao study when discussing gabapentinoids and serotonin syndrome risk.¹⁵ The practical concern isn’t that gabapentin alone will flood your system with serotonin. It’s that if you’re already taking drugs that raise serotonin, such as certain antidepressants, opioids like tramadol or fentanyl, or migraine medications like triptans, gabapentin’s modest and poorly understood serotonergic influence could add just enough to tip the balance in rare cases.

If you’re taking gabapentin alongside any medication known to affect serotonin, be aware of serotonin syndrome symptoms: agitation, rapid heartbeat, dilated pupils, muscle twitching or rigidity, heavy sweating, and in severe cases, high fever. This is not common with gabapentin, and it almost always involves a combination of drugs, but it’s a situation where being informed matters.

Why the Confusion Persists

Part of the confusion about gabapentin and serotonin stems from the fact that the drug does things that feel serotonergic to patients. It can reduce anxiety, improve sleep quality, and sometimes lift mood, all effects people associate with serotonin-related medications. But these effects are better explained by gabapentin’s well-documented actions on calcium channels and brain GABA levels than by any serotonin mechanism. Anxiety and sleep are not governed by a single neurotransmitter, and boosting GABA can produce improvements in both without serotonin being involved at all.

Another source of confusion is the language used in pharmacology literature. Gabapentin is sometimes described as having “serotonergic properties,” which sounds definitive but usually refers back to the same handful of observations: the small whole-blood study from the 1980s, the interaction with serotonergic pain circuits, and the occasional case reports of serotonin syndrome in patients on multiple drugs. These are real observations, but they paint a picture of indirect, modest, and context-dependent interactions rather than a reliable serotonin-boosting effect.

How Gabapentin Compares to Drugs That Do Raise Serotonin

For context, consider how fundamentally different gabapentin’s pharmacology is from drugs designed to increase serotonin. SSRIs block the serotonin transporter, directly preventing serotonin from being cleared out of the synapse. SNRIs do the same thing to both serotonin and noradrenaline transporters. MAO inhibitors prevent the enzyme that breaks serotonin down. Each of these drug classes has a defined, reproducible mechanism for raising synaptic serotonin, and the clinical effects flow predictably from that mechanism.

Gabapentin has none of these properties. It doesn’t block serotonin reuptake. It doesn’t inhibit the enzymes that break serotonin down. It doesn’t stimulate serotonin receptors directly. Its sole confirmed molecular target is a calcium channel accessory protein. The serotonin effects that have been observed are inconsistent across studies, dependent on context, and often in the opposite direction of what you’d expect if gabapentin were truly a serotonergic drug. In the cisplatin vomiting model, it reduced serotonin; in the Rao blood study, it appeared to raise it; in spinal cord measurements, it did neither.

This inconsistency itself is informative. A drug that reliably increases serotonin produces consistent, reproducible effects on serotonin across different tissues and experimental conditions. Gabapentin does not. Its relationship with serotonin looks more like a bystander effect of broadly dampening excitatory neurotransmission than like targeted serotonergic activity.

Peripheral Serotonin and the Gut

One angle that rarely gets discussed in the gabapentin conversation is the massive reservoir of serotonin outside the brain. The gut’s enterochromaffin cells produce the vast majority of the body’s serotonin, and platelets circulating in the blood absorb and store large quantities of it. The whole-blood serotonin increase observed in the Rao study may reflect changes in this peripheral pool rather than anything happening in the brain.

Gabapentin is absorbed in the small intestine, and the LAT1 transporter that carries it into the brain is also expressed in gut tissue.⁴ Whether gabapentin’s presence in the gut could influence local serotonin dynamics is an open question. The cisplatin vomiting study, which found that gabapentin attenuated chemotherapy-induced serotonin surges, hints at a peripheral serotonin interaction in the gut, but in a serotonin-lowering direction rather than a serotonin-raising one.¹³

For patients or clinicians wondering about gabapentin’s effects on serotonin-sensitive conditions like irritable bowel syndrome, carcinoid syndrome, or other disorders where peripheral serotonin plays a role, the honest answer is that we don’t know enough. The evidence base consists of a few animal studies and one very small human study from over three decades ago. No one has conducted the kind of controlled trials that would be needed to make confident claims about gabapentin’s effects on gut or blood serotonin in clinical populations.

What This Means If You Take Gabapentin

If your doctor prescribed gabapentin and you’re wondering whether it’s going to affect your serotonin the way an antidepressant would, the answer is almost certainly not in any clinically meaningful way. The drug’s benefits for pain, seizures, and anxiety come primarily from its calcium channel and GABA-related mechanisms, not from serotonin modulation. You should not expect gabapentin to serve as a substitute for an SSRI or SNRI if you need serotonin-based treatment for depression or anxiety disorders.

If you are already taking a medication that raises serotonin and your provider adds gabapentin, the combination is generally considered safe. The serotonin syndrome cases in the literature overwhelmingly involve patients on multiple strong serotonergic agents, with gabapentin as one drug among several. Still, knowing the theoretical possibility exists is worthwhile, especially if you’re on complex medication regimens. Mention all your medications when any new one is added, and be aware of serotonin syndrome symptoms even when the individual risk from gabapentin appears low.